Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System
K-Number: K182047 · 2018-11-29
Device Summary
Frequently Asked Questions
What is the Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2018-11-29. It is manufactured by Tyson Bioresearch, Inc.. The 510(k) number is K182047.
When was Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System approved by the FDA?
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System received FDA 510(k) clearance on 2018-11-29, under approval number K182047.
What company makes Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System is manufactured by Tyson Bioresearch, Inc..
What is the FDA product code for Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
The FDA product code for Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
Related Clinical Trials
Related PubMed Literature
Other Devices by Tyson Bioresearch, Inc.
Related Devices (Code: NBW)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.